相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Direct carborane-peptide conjugates: Synthesis and evaluation as non natural lipopeptide mimetics
Tamara Luetzenburg et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2018)
Towards carborane-functionalised structures for the treatment of brain cancer
Gianpiero Calabrese et al.
DRUG DISCOVERY TODAY (2018)
Development of Albumin-closo-Dodecaborate Conjugates as Boron Carriers for Neutron-Capture Therapy by Ru(bpy)3-Photocatalyzed Modification of Tyrosine
Shinichi Sato et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2017)
C-Terminus of a Hexapeptidic Ghrelin Receptor Inverse Agonist Can Switch Peptide Behavior From Inverse Agonism to Agonism
Sylvia Els-Heindl et al.
BIOPOLYMERS (2016)
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model
Yoshiya Iguchi et al.
BIOMATERIALS (2015)
High metabolic in vivo stability and bioavailability of a palmitoylated ghrelin receptor ligand assessed by mass spectrometry
Katja B. Kostelnik et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy
Micah John Luderer et al.
PHARMACEUTICAL RESEARCH (2015)
Receptor-Mediated Uptake of Boron-Rich Neuropeptide Y Analogues for Boron Neutron Capture Therapy
Verena M. Ahrens et al.
CHEMMEDCHEM (2015)
The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide
Hiroyuki Michiue et al.
BIOMATERIALS (2014)
MECHANISMS IN ENDOCRINOLOGY Regulation of glucose metabolism by the ghrelin system: multiple players and multiple actions
Kristy M. Heppner et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
N3-substituted thymidine bioconjugates for cancer therapy and imaging
Ahmed Khalil et al.
FUTURE MEDICINAL CHEMISTRY (2013)
An Aromatic Region To Induce a Switch between Agonism and Inverse Agonism at the Ghrelin Receptor
Sylvia Els et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer
Rolf F. Barth et al.
RADIATION ONCOLOGY (2012)
Synthesis and evaluation of cyclic RGD-boron cluster conjugates to develop tumor-selective boron carriers for boron neutron capture therapy
Sadaaki Kimura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Carbaboranes as Pharmacophores: Properties, Synthesis, and Application Strategies
Matthias Scholz et al.
CHEMICAL REVIEWS (2011)
Unique Interaction Pattern for a Functionally Biased Ghrelin Receptor Agonist
Bjorn Sivertsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Incorporation of ortho-Carbaboranyl-Nε-Modified L-Lysine into Neuropeptide Y Receptor Y1- and Y2-Selective Analogues
Verena M. Ahrens et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Structure-Activity Relationships of GHRP-6 Azapeptide Ligands of the CD36 Scavenger Receptor by Solid-Phase Submonomer Azapeptide Synthesis
David Sabatino et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Ghrelin: A potential therapeutic target for cancer
Dimitrios Nikolopoulos et al.
REGULATORY PEPTIDES (2010)
A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: In vitro and in vivo studies
G. Jori et al.
APPLIED RADIATION AND ISOTOPES (2009)
Biological evaluation of boronated unnatural amino acids as new boron carriers
G. W. Kabalka et al.
APPLIED RADIATION AND ISOTOPES (2009)
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
Weilian Yang et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Biodistribution of 10B for Boron Neutron Capture Therapy (BNCT) in a Mouse Model after Injection of Sodium Mercaptoundecahydro-closo-dodecaborate and L-para-Boronophenylalanine
Andrea Wittig et al.
RADIATION RESEARCH (2009)
closo-borane conjugated regulatory peptides retain high biological affinity:: Synthesis of closo-borane conjugated Tyr3-octreotate derivatives for BNCT
Thomas Betzel et al.
BIOCONJUGATE CHEMISTRY (2008)
Identification of an efficacy switch region in the ghrelin receptor responsible for interchange between agonism and inverse agonism
Birgitte Holst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Ghrelin and the growth hormone secretagogue receptor constitute a novel autocrine pathway in astrocytoma motility
Vishwa Deep Dixit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting normal and neoplastic tissues in the rat jejunum and colon with boronated, cationic acrylamide copolymers
AK Azab et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Boron neutron capture therapy of cancer: Current status and future prospects
RF Barth et al.
CLINICAL CANCER RESEARCH (2005)
Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors
F Gaytan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Identification of the growth hormone-releasing peptide binding site in CD36: a photoaffinity cross-linking study
A Demers et al.
BIOCHEMICAL JOURNAL (2004)
Conjugation of the closo-borane mereaptoundecahydrododecaborate (BSH) to a tumour selective peptide
W Mier et al.
ZEITSCHRIFT FUR ANORGANISCHE UND ALLGEMEINE CHEMIE (2004)
Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy
G Wu et al.
BIOCONJUGATE CHEMISTRY (2004)
Synthesis of a Tyr3-octreotate conjugated closo-carborane [HC2B10H10]:: a potential compound for boron neutron capture therapy
E Schirrmacher et al.
TETRAHEDRON LETTERS (2003)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
High constitutive signaling of the ghrelin receptor - Identification of a potent inverse agonist
B Holst et al.
MOLECULAR ENDOCRINOLOGY (2003)
The medicinal chemistry of carboranes
JF Valliant et al.
COORDINATION CHEMISTRY REVIEWS (2002)
CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart
V Bodart et al.
CIRCULATION RESEARCH (2002)
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines
PL Jeffery et al.
JOURNAL OF ENDOCRINOLOGY (2002)